In addition, IL-21 promoted the viability of the primary cells and of the EBV-positive DLBCL cell line Farage, but reduced viability in the EBV-negative DLBCL cell line MC116 (Fig. 1b). The gene discussed is IL21; the disease is diffuse large B-cell lymphoma.